TTK Healthcare Limited has informed the Exchange regarding 'Annual Report for the FY 2024-25'.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 0.8 pts less than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TTK Healthcare has submitted its 67th Annual Report for FY 2024-25, with the Annual General Meeting scheduled for July 25, 2025 at 12:00 noon via video conferencing. For FY24-25, revenue from continuing operations rose to Rs.872.75 crores from Rs.815.40 crores, a growth of about 7%. Profit after tax grew roughly 30% to Rs.81.66 crores, up from Rs.62.84 crores in the previous year. EBITDA expanded to Rs.119.98 crores from Rs.99.93 crores, a jump of about 20%. Both PAT and PBT figures include exceptional items, as flagged in the report. The Board has recommended a 100% dividend (Rs.10 per share of Rs.10 face value), unchanged from the prior year. Shareholders will also consider the appointment of a new secretarial auditor for five years and ratification of the cost auditor's remuneration.
Strong year for shareholders with a 30% jump in profits and sustained 100% dividend. The presence of exceptional items in the profit numbers means core operating performance may be more modest than headline PAT suggests, warranting a closer look at the report's notes.